[Form 4] Inspire Veterinary Partners, Inc. Insider Trading Activity
Lawrence Alexander, a director of Inspire Veterinary Partners, reported acquiring stock options that give the right to purchase 1,447 shares of Class A Common Stock at an exercise price of $17. The options were recorded with a transaction date of 09/26/2024, are exercisable on 09/26/2024 and expire on 09/26/2034, and are held in a direct ownership form.
The filing notes a corporate action that adjusted reported share counts: the issuer effected a 25-to-1 reverse stock split on 01/27/2025, and the numbers on this Form 4 were updated to reflect that split. The report shows 1,447 options outstanding following the transaction, representing the right to buy 1,447 Class A shares at the stated price until 2034.
Lawrence Alexander, direttore di Inspire Veterinary Partners, ha dichiarato di aver acquisito opzioni su azioni che danno il diritto di acquistare 1,447 azioni di Classe A al prezzo di esercizio di $17. Le opzioni sono state registrate con data operazione 09/26/2024, sono esercitabili dal 09/26/2024, scadono il 09/26/2034 e sono detenute in forma diretta.
La comunicazione segnala inoltre un'operazione societaria che ha corretto i numeri segnalati: l'emittente ha effettuato un reverse stock split 25-a-1 il 01/27/2025 e i valori nel Modulo 4 sono stati aggiornati di conseguenza. Dopo l'operazione risultano in essere 1,447 opzioni, pari al diritto di acquistare 1,447 azioni di Classe A al prezzo indicato fino al 2034.
Lawrence Alexander, director de Inspire Veterinary Partners, inform贸 la adquisici贸n de opciones sobre acciones que otorgan el derecho a comprar 1,447 acciones de Clase A a un precio de ejercicio de $17. Las opciones se registraron con fecha de transacci贸n 09/26/2024, son ejercitables desde 09/26/2024, vencen el 09/26/2034 y est谩n en forma de propiedad directa.
La presentaci贸n indica una acci贸n corporativa que ajust贸 los recuentos reportados: el emisor realiz贸 un split inverso 25 a 1 el 01/27/2025 y las cifras en este Formulario 4 se actualizaron para reflejarlo. Tras la operaci贸n hay 1,447 opciones en circulaci贸n, que representan el derecho a comprar 1,447 acciones de Clase A al precio indicado hasta 2034.
Lawrence Alexander鞚� Inspire Veterinary Partners鞚� 鞚挫偓搿滌劀 頄夓偓 臧�瓴� $17鞙茧 1,447欤检潣 韥措灅鞀� A 氤错喌欤茧ゼ 毵れ垬頃� 靾� 鞛堧姅 鞀ろ啞鞓奠厴鞚� 旆摑頄堧嫟瓿� 氤搓碃頄堨姷雼堧嫟. 頃措嫻 鞓奠厴鞚� 瓯半灅鞚检澊 09/26/2024搿� 旮办灛霅橃柎 鞛堦碃, 09/26/2024攵�韯� 頄夓偓 臧�電ロ晿氅� 09/26/2034鞐� 毵岆霅橂┌ 歆侅为 靻岇湢 順曧儨鞛呺媹雼�.
鞁犼碃靹滌棎電� 氤搓碃霅� 欤检嫕 靾橂ゼ 臁办爼頃� 旮办梾 臁办箻臧� 旮办灛霅橃柎 鞛堨姷雼堧嫟: 氚滍枆靷姅 01/27/2025鞐� 25雽�1 鞐秳頃�鞚� 鞁れ嫓頄堨溂氅� 鞚� Form 4鞚� 靾橃箻電� 攴胳棎 毵炾矊 鞐呺嵃鞚错姼霅橃棃鞀惦媹雼�. 瓯半灅 鞚错泟 1,447鞓奠厴鞚� 鞛旍〈頃橂┌, 鞚措姅 2034雲勱箤歆� 氇呾嫓霅� 臧�瓴╈溂搿� 1,447欤检潣 韥措灅鞀� A 欤检嫕鞚� 毵れ垬頃� 甓岆Μ毳� 鞚橂頃╇媹雼�.
Lawrence Alexander, administrateur d'Inspire Veterinary Partners, a d茅clar茅 l'acquisition d'options donnant le droit d'acheter 1听447 actions de cat茅gorie A au prix d'exercice de $17. Les options ont 茅t茅 enregistr茅es avec une date de transaction du 09/26/2024, sont exer莽ables 脿 partir du 09/26/2024, expirent le 09/26/2034 et sont d茅tenues en propri茅t茅 directe.
Le d茅p么t signale 茅galement une op茅ration d'entreprise ayant ajust茅 les totaux rapport茅s聽: l'茅metteur a proc茅d茅 脿 un reverse split 25 pour 1 le 01/27/2025 et les chiffres de ce Formulaire 4 ont 茅t茅 mis 脿 jour en cons茅quence. 脌 la suite de l'op茅ration, 1听447 options restent en circulation, repr茅sentant le droit d'acheter 1听447 actions de cat茅gorie A au prix indiqu茅 jusqu'en 2034.
Lawrence Alexander, Direktor von Inspire Veterinary Partners, meldete den Erwerb von Aktienoptionen, die das Recht geben, 1.447 Class鈥慉鈥慉ktien zum Aus眉bungspreis von $17 zu kaufen. Die Optionen wurden mit dem Transaktionsdatum 09/26/2024 erfasst, sind ab dem 09/26/2024 aus眉bbar, laufen am 09/26/2034 ab und werden in direktem Eigentum gehalten.
Die Meldung weist auf eine unternehmensseitige Ma脽nahme hin, die die angegebenen St眉ckzahlen angepasst hat: Der Emittent f眉hrte am 01/27/2025 einen 25鈥憐u鈥�1 Reverse鈥慡plit durch, und die Zahlen im Formular 4 wurden entsprechend aktualisiert. Nach der Transaktion sind 1.447 Optionen ausstehend, die das Recht darstellen, bis 2034 jeweils 1.447 Class鈥慉鈥慉ktien zum genannten Preis zu erwerben.
- Director acquisition: Lawrence Alexander acquired 1,447 stock options, signaling insider participation in equity incentives.
- Clear option terms: Options have a specified $17 exercise price, immediate exercisability (09/26/2024) and a defined expiration (09/26/2034), providing transparency.
- None.
Insights
TL;DR: Director received 1,447 options at $17, immediately exercisable, adjusted for a 25:1 reverse split; impact appears limited.
The transaction is an insider option grant recorded as an acquisition of 1,447 derivatives exercisable the same day and expiring in 2034. For investors this is a routine executive compensation event rather than a material capital change: the absolute option count is small and exercise price is explicit at $17. The 25:1 reverse split is a meaningful capital-structure event that affects per-share metrics, but the filing does not disclose other equity changes or large dilution from this grant alone.
TL;DR: Immediate exercisability and long expiration window are notable governance details; overall disclosure is straightforward.
The report documents direct beneficial ownership of 1,447 options by a board director with exercisability effective upon grant and a ten-year term, which is consistent with standard equity incentives. The filing also records a 25:1 reverse stock split that required adjustment of reported amounts. No additional governance issues, departures, or related-party terms are disclosed in this filing; the items presented are specific and limited in scope.
Lawrence Alexander, direttore di Inspire Veterinary Partners, ha dichiarato di aver acquisito opzioni su azioni che danno il diritto di acquistare 1,447 azioni di Classe A al prezzo di esercizio di $17. Le opzioni sono state registrate con data operazione 09/26/2024, sono esercitabili dal 09/26/2024, scadono il 09/26/2034 e sono detenute in forma diretta.
La comunicazione segnala inoltre un'operazione societaria che ha corretto i numeri segnalati: l'emittente ha effettuato un reverse stock split 25-a-1 il 01/27/2025 e i valori nel Modulo 4 sono stati aggiornati di conseguenza. Dopo l'operazione risultano in essere 1,447 opzioni, pari al diritto di acquistare 1,447 azioni di Classe A al prezzo indicato fino al 2034.
Lawrence Alexander, director de Inspire Veterinary Partners, inform贸 la adquisici贸n de opciones sobre acciones que otorgan el derecho a comprar 1,447 acciones de Clase A a un precio de ejercicio de $17. Las opciones se registraron con fecha de transacci贸n 09/26/2024, son ejercitables desde 09/26/2024, vencen el 09/26/2034 y est谩n en forma de propiedad directa.
La presentaci贸n indica una acci贸n corporativa que ajust贸 los recuentos reportados: el emisor realiz贸 un split inverso 25 a 1 el 01/27/2025 y las cifras en este Formulario 4 se actualizaron para reflejarlo. Tras la operaci贸n hay 1,447 opciones en circulaci贸n, que representan el derecho a comprar 1,447 acciones de Clase A al precio indicado hasta 2034.
Lawrence Alexander鞚� Inspire Veterinary Partners鞚� 鞚挫偓搿滌劀 頄夓偓 臧�瓴� $17鞙茧 1,447欤检潣 韥措灅鞀� A 氤错喌欤茧ゼ 毵れ垬頃� 靾� 鞛堧姅 鞀ろ啞鞓奠厴鞚� 旆摑頄堧嫟瓿� 氤搓碃頄堨姷雼堧嫟. 頃措嫻 鞓奠厴鞚� 瓯半灅鞚检澊 09/26/2024搿� 旮办灛霅橃柎 鞛堦碃, 09/26/2024攵�韯� 頄夓偓 臧�電ロ晿氅� 09/26/2034鞐� 毵岆霅橂┌ 歆侅为 靻岇湢 順曧儨鞛呺媹雼�.
鞁犼碃靹滌棎電� 氤搓碃霅� 欤检嫕 靾橂ゼ 臁办爼頃� 旮办梾 臁办箻臧� 旮办灛霅橃柎 鞛堨姷雼堧嫟: 氚滍枆靷姅 01/27/2025鞐� 25雽�1 鞐秳頃�鞚� 鞁れ嫓頄堨溂氅� 鞚� Form 4鞚� 靾橃箻電� 攴胳棎 毵炾矊 鞐呺嵃鞚错姼霅橃棃鞀惦媹雼�. 瓯半灅 鞚错泟 1,447鞓奠厴鞚� 鞛旍〈頃橂┌, 鞚措姅 2034雲勱箤歆� 氇呾嫓霅� 臧�瓴╈溂搿� 1,447欤检潣 韥措灅鞀� A 欤检嫕鞚� 毵れ垬頃� 甓岆Μ毳� 鞚橂頃╇媹雼�.
Lawrence Alexander, administrateur d'Inspire Veterinary Partners, a d茅clar茅 l'acquisition d'options donnant le droit d'acheter 1听447 actions de cat茅gorie A au prix d'exercice de $17. Les options ont 茅t茅 enregistr茅es avec une date de transaction du 09/26/2024, sont exer莽ables 脿 partir du 09/26/2024, expirent le 09/26/2034 et sont d茅tenues en propri茅t茅 directe.
Le d茅p么t signale 茅galement une op茅ration d'entreprise ayant ajust茅 les totaux rapport茅s聽: l'茅metteur a proc茅d茅 脿 un reverse split 25 pour 1 le 01/27/2025 et les chiffres de ce Formulaire 4 ont 茅t茅 mis 脿 jour en cons茅quence. 脌 la suite de l'op茅ration, 1听447 options restent en circulation, repr茅sentant le droit d'acheter 1听447 actions de cat茅gorie A au prix indiqu茅 jusqu'en 2034.
Lawrence Alexander, Direktor von Inspire Veterinary Partners, meldete den Erwerb von Aktienoptionen, die das Recht geben, 1.447 Class鈥慉鈥慉ktien zum Aus眉bungspreis von $17 zu kaufen. Die Optionen wurden mit dem Transaktionsdatum 09/26/2024 erfasst, sind ab dem 09/26/2024 aus眉bbar, laufen am 09/26/2034 ab und werden in direktem Eigentum gehalten.
Die Meldung weist auf eine unternehmensseitige Ma脽nahme hin, die die angegebenen St眉ckzahlen angepasst hat: Der Emittent f眉hrte am 01/27/2025 einen 25鈥憐u鈥�1 Reverse鈥慡plit durch, und die Zahlen im Formular 4 wurden entsprechend aktualisiert. Nach der Transaktion sind 1.447 Optionen ausstehend, die das Recht darstellen, bis 2034 jeweils 1.447 Class鈥慉鈥慉ktien zum genannten Preis zu erwerben.
FAQ
What transaction did Lawrence Alexander report on Form 4 for IVP?
What are the exercisability and expiration dates for the options reported?
What is Lawrence Alexander's relationship to Inspire Veterinary Partners (IVP)?
Did the company adjust reported share counts, and why?
How many Class A shares do the options cover?
Is ownership direct or indirect according to the filing?
